Literature DB >> 28017863

Metabolomic profiling of prostate cancer by matrix assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry imaging using Matrix Coating Assisted by an Electric Field (MCAEF).

Xiaodong Wang1, Jun Han1, Darryl B Hardie1, Juncong Yang1, Jingxi Pan1, Christoph H Borchers2.   

Abstract

In this work, we combined the use of two MALDI matrices (quercetin and 9-aminoacridine), a recently developed new matrix coating technique - matrix coating assisted by an electric field (MCAEF), and matrix-assisted laser desorption/ionization - Fourier transform ion cyclotron resonance mass spectrometry (MALDI-FTICRMS) to detect and image endogenous compounds in the cancerous and non-cancerous regions of three human prostate cancer (stage II) tissue specimens. After three rounds of imaging data acquisitions (i.e., quercetin for positive and negative ion detection and 9-aminoacridine for negative ion detection), and metabolite identification, a total of 1091 metabolites including 1032 lipids and 59 other metabolites were routinely detected and successfully localized. Of these compounds, 250 and 217 were only detected in either the cancerous or the non-cancerous regions respectively, although we cannot rule out the presence of these metabolites at concentrations below the detection limit. In addition, 152 of the other 624 metabolites showed differential distributions (p<0.05, t-test) between the two regions of the tissues. Further studies on a larger number of clinical specimens will need to be carried out to confirm this large number of apparently cancer-related metabolites. The successful determination of the spatial locations and abundances of these endogenous biomolecules indicated significant metabolism abnormalities - e.g., increased energy charge and under-expression of neutral acyl glycerides, in the prostate cancer samples. To our knowledge, this work has resulted in MALDI-MS imaging of the largest group of metabolites in prostate cancer thus far and demonstrated the importance of using complementary matrices for comprehensive metabolomic imaging by MALDI-MS. This article is part of a Special Issue entitled: MALDI Imaging, edited by Dr. Corinna Henkel and Prof. Peter Hoffmann.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Lipid; MCAEF; Primary metabolite; Prostate cancer; Tissue imaging

Mesh:

Substances:

Year:  2016        PMID: 28017863     DOI: 10.1016/j.bbapap.2016.12.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  14 in total

1.  Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma.

Authors:  Elizabeth C Randall; Begoña G C Lopez; Sen Peng; Michael S Regan; Walid M Abdelmoula; Sankha S Basu; Sandro Santagata; Haejin Yoon; Marcia C Haigis; Jeffrey N Agar; Nhan L Tran; William F Elmquist; Forest M White; Jann N Sarkaria; Nathalie Y R Agar
Journal:  Cancer Res       Date:  2019-11-25       Impact factor: 12.701

2.  Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging.

Authors:  Elizabeth C Randall; Giorgia Zadra; Paolo Chetta; Begona G C Lopez; Sudeepa Syamala; Sankha S Basu; Jeffrey N Agar; Massimo Loda; Clare M Tempany; Fiona M Fennessy; Nathalie Y R Agar
Journal:  Mol Cancer Res       Date:  2019-02-11       Impact factor: 5.852

3.  Anticancer Drug Affects Metabolomic Profiles in Multicellular Spheroids: Studies Using Mass Spectrometry Imaging Combined with Machine Learning.

Authors:  Xiang Tian; Genwei Zhang; Zhu Zou; Zhibo Yang
Journal:  Anal Chem       Date:  2019-04-15       Impact factor: 6.986

4.  MALDI Mass Spectrometry Imaging Highlights Specific Metabolome and Lipidome Profiles in Salivary Gland Tumor Tissues.

Authors:  Eduardo Sommella; Emanuela Salviati; Vicky Caponigro; Manuela Grimaldi; Simona Musella; Alessia Bertamino; Luigi Cacace; Remo Palladino; Giuseppe Di Mauro; Federico Marini; Anna Maria D'Ursi; Pietro Campiglia
Journal:  Metabolites       Date:  2022-06-08

5.  An optimized MALDI MSI protocol for spatial detection of tryptic peptides in fresh frozen prostate tissue.

Authors:  Therese S Høiem; Maria K Andersen; Marta Martin-Lorenzo; Rémi Longuespée; Britt S R Claes; Anna Nordborg; Frédéric Dewez; Benjamin Balluff; Marco Giampà; Animesh Sharma; Lars Hagen; Ron M A Heeren; Tone F Bathen; Guro F Giskeødegård; Sebastian Krossa; May-Britt Tessem
Journal:  Proteomics       Date:  2022-03-03       Impact factor: 5.393

Review 6.  Prostate cancer diagnosis and characterization with mass spectrometry imaging.

Authors:  Annika Kurreck; Lindsey A Vandergrift; Taylor L Fuss; Piet Habbel; Nathalie Y R Agar; Leo L Cheng
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-12-05       Impact factor: 5.554

7.  Quantitative MALDI Imaging of Spatial Distributions and Dynamic Changes of Tetrandrine in Multiple Organs of Rats.

Authors:  Weiwei Tang; Jun Chen; Jie Zhou; Junyue Ge; Ying Zhang; Ping Li; Bin Li
Journal:  Theranostics       Date:  2019-01-25       Impact factor: 11.556

8.  Evaluation of lipid coverage and high spatial resolution MALDI-imaging capabilities of oversampling combined with laser post-ionisation.

Authors:  Andrew P Bowman; Jeroen F J Bogie; Jerome J A Hendriks; Mansour Haidar; Mikhail Belov; Ron M A Heeren; Shane R Ellis
Journal:  Anal Bioanal Chem       Date:  2019-12-26       Impact factor: 4.142

9.  Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI.

Authors:  Maria K Andersen; Therese S Høiem; Britt S R Claes; Benjamin Balluff; Marta Martin-Lorenzo; Elin Richardsen; Sebastian Krossa; Helena Bertilsson; Ron M A Heeren; Morten B Rye; Guro F Giskeødegård; Tone F Bathen; May-Britt Tessem
Journal:  Cancer Metab       Date:  2021-01-29

Review 10.  Metabolic Constrains Rule Metastasis Progression.

Authors:  Niccolo' Roda; Valentina Gambino; Marco Giorgio
Journal:  Cells       Date:  2020-09-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.